North America Pharmaceutical Excipients Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins and Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents, and Others), Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical, and Others), and End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)   


No. of Pages: 256    |    Report Code: TIPRE00022815    |    Category: Chemicals and Materials

North America Pharmaceutical Excipients Market
Buy Now

The North America pharmaceutical excipients market is expected to grow from US$ 3,715.72 million in 2022 to US$ 5,326.59 million by 2028. It is estimated to register a CAGR of 6.2% from 2022 to 2028.

 

Increasing Product Launches is fueling the growth of North America pharmaceutical excipients market

 

The pharmaceutical excipients market is characterized by the presence of large and small market players. A few product launches have taken place in recent years. For instance, in October 2022, Rouqette, a pharmaceutical and nutraceutical excipients provider, launched two next-generation mannitol products—PEARLITOL CR-H and PEARLITOL 200 GT— for direct compression. These excipients have been specially formulated to overcome the unique drug formulation challenges in the pharmaceutical spaces, which helps the manufacturers optimize direct compression processes and expand into application areas such as mini tabs and controlled-release tablets. Similarly, in March 2022, Lubrizol Life Science Health launched Apisolex, a novel solubility-enhancing excipient for parenteral drug products. With the ability to improve solubility by up to 50,000-fold and support high drug loading, Apisolex excipient provides access to new and improved parenteral drug products. This is especially relevant in oncology, as direct injection of drugs into the bloodstream ensures higher bioavailability and lower patient variability compared to oral delivery. Similarly, in April 2021, DFE Pharma, the pharmaceutical excipient solution provider, launched its new product line, BioHale, a solution for biopharmaceutical manufacturers. With the launch of BioHale Sucrose, DFE Pharma offers exceptional market purity and low endotoxin excipient to be used in the formulation. The active participation of market players in product innovation and development, leading to the increase in product launches, is fueling the growth of the North America pharmaceutical excipients market.

 

North America Pharmaceutical Excipients Market Overview

The North America pharmaceutical excipients market is segmented into the US, Canada, and Mexico. The US held the largest share of the North American pharmaceutical excipients market in 2021. In North America, economic prosperity and a rise in demand for pharmaceuticals have boosted drug production. Consequently, excipient consumption is a key factor driving a gradual increase in manufacturing expenditures. Within the pharmaceutical industry, the falling price pressure lowered R&D productivity, and stringent regulations have prompted drug manufacturers to progressively turn to produce excipients with the intent to develop differentiated and value-adding products at low prices without compromising quality. The pharmaceutical industry has continuously been one of the most advanced research and development industries in the US. According to the International Trade Administration report in 2016, the research-based industry generally allocates ~15–20% of revenues to R&D activities and invests over US$ 50 billion in R&D annually. The US remains the global leader in innovative R&D investment. Thus, the research activities that fuel new drug manufacturing have a positive impact on the use of pharmaceutical excipients in dosage forms.

 

North America Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)

 

North America Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report

North America Pharmaceutical Excipients Strategic Insights

Strategic insights for the North America Pharmaceutical Excipients provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/north-america-pharmaceutical-excipients-market-strategic-framework.webp
Get more information on this report

North America Pharmaceutical Excipients Report Scope

Report Attribute Details
Market size in 2022 US$ 3,715.72 Million
Market Size by 2028 US$ 5,326.59 Million
Global CAGR (2022 - 2028) 6.2%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Type
  • Bioresorbable Polymers
  • Lipids and Liposome-Based Formulation
  • Oleochemicals
  • Sugars
  • Cellulose
  • Starches
  • Petrochemicals
  • Plant Proteins and Polyols and Cyclodextrins
  • Inorganic Chemicals
By Clinical Indication
  • Cancer
  • Metabolic
  • Infectious Diseases
  • Dental
  • Ophthalmic
  • Gene Therapies
By Functionality
  • Coloring Agent and Coating Agent
  • Sweetener and Flavoring Agents
  • Suspending and Viscosity Agents
  • Preservative and Controlled-Release
  • Antioxidant and Oil
  • Tablet Filler and Diluents
  • Binders and Compression Aids and Granulating Agents
By Application
  • Parenteral
  • Oral Formulations and Tablets
  • Capsules
  • Liquid and Injectables
  • Physicochemical Excipient-Container Interactions in Prefilled Syringes
  • Nutraceuticals and OTC
  • Topical
By End User
  • Biopharma Industries
  • Pharma Industries
  • Animal Health
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Archer-Daniels-Midland Co
  • AshLand Inc
  • Avantor Inc
  • BASF SE
  • Evonik Industries AG
  • JRS PHARMA GmbH & Co. KG
  • MEGGLE GmbH & Co KG
  • Roquette Freres SA
  • The Dow Chemical Co
  • The Lubrizol Corp
  • Get more information on this report

    North America Pharmaceutical Excipients Regional Insights

    The geographic scope of the North America Pharmaceutical Excipients refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/north-america-pharmaceutical-excipients-market-geography.webp
    Get more information on this report

    North America Pharmaceutical Excipients Market Segmentation

     

    The North America pharmaceutical excipients market is segmented into type, clinical indication, functionality, application, end user, and country. Based on type, the North America pharmaceutical excipients market is segmented into bioresorbable polymers & lipids & liposome-based formulation, oleochemicals, sugars, cellulose, starches, petrochemicals, plant protein & polyols & cyclodextrins, inorganic chemicals, and others. The inorganic chemicals segment registered the largest market share in 2022.

     

    Based on clinical indication, the North America pharmaceutical excipients market is segmented into cancer, metabolic, infectious diseases, dental, ophthalmic, gene therapies, and others. The cancer segment registered the largest market share in 2022.

     

    Based on functionality, the North America pharmaceutical excipients market is segmented into coloring agent & coating agents, sweetener & flavoring agents, suspending & viscosity agents, preservative & controlled-release, antioxidant & oil, tablet filler & diluents, binders & compression aids & granulating agents, emulsifiers, and others. The tablet filler and diluents segment registered the largest market share in 2022.

     

    Based on application, the North America pharmaceutical excipients market is segmented into parenteral, orals formulations & tablets, capsules, liquid & injectable, physicochemical excipient container interactions in prefilled syringes, nutraceuticals & OTC, topical, and others. The orals formulations & tablets segment registered the largest market share in 2022.

     

    Based on end user, the North America pharmaceutical excipients market is segmented into biopharma industries, pharma industries, animal health, and others. The pharma industries segment registered the largest market share in 2022.

     

    Based on country, the North America pharmaceutical excipients market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.

     

    Archer-Daniels-Midland Co, AshLand Inc, Avantor Inc, BASF SE, Evonik Industries AG, JRS PHARMA GmbH & Co. KG, MEGGLE GmbH & Co KG, Roquette Freres SA, The Dow Chemical Co, and The Lubrizol Corp are among the leading companies operating in the North America pharmaceutical excipients market.

    The List of Companies - North America Pharmaceutical Excipients Market

    1. Archer-Daniels-Midland Co
    2. AshLand Inc
    3. Avantor Inc
    4. BASF SE
    5. Evonik Industries AG
    6. JRS PHARMA GmbH & Co. KG
    7. MEGGLE GmbH & Co KG
    8. Roquette Freres SA
    9. The Dow Chemical Co
    10. The Lubrizol Corp
    Frequently Asked Questions
    How big is the North America Pharmaceutical Excipients Market?

    The North America Pharmaceutical Excipients Market is valued at US$ 3,715.72 Million in 2022, it is projected to reach US$ 5,326.59 Million by 2028.

    What is the CAGR for North America Pharmaceutical Excipients Market by (2022 - 2028)?

    As per our report North America Pharmaceutical Excipients Market, the market size is valued at US$ 3,715.72 Million in 2022, projecting it to reach US$ 5,326.59 Million by 2028. This translates to a CAGR of approximately 6.2% during the forecast period.

    What segments are covered in this report?

    The North America Pharmaceutical Excipients Market report typically cover these key segments-

    • Type (Bioresorbable Polymers, Lipids and Liposome-Based Formulation, Oleochemicals, Sugars, Cellulose, Starches, Petrochemicals, Plant Proteins and Polyols and Cyclodextrins, Inorganic Chemicals ,)
    • Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies)
    • Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents)
    • Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical)
    • End User (Biopharma Industries, Pharma Industries, Animal Health)

    What is the historic period, base year, and forecast period taken for North America Pharmaceutical Excipients Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pharmaceutical Excipients Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in North America Pharmaceutical Excipients Market?

    The North America Pharmaceutical Excipients Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Archer-Daniels-Midland Co
  • AshLand Inc
  • Avantor Inc
  • BASF SE
  • Evonik Industries AG
  • JRS PHARMA GmbH & Co. KG
  • MEGGLE GmbH & Co KG
  • Roquette Freres SA
  • The Dow Chemical Co
  • The Lubrizol Corp
  • Who should buy this report?

    The North America Pharmaceutical Excipients Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Pharmaceutical Excipients Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now